White Papers

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients 204 115 Shields Health Solutions

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
The Impact of Specialty Pharmacy on Clinician Allocation 204 115 Shields Health Solutions

The Impact of Specialty Pharmacy on Clinician Allocation
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model 204 115 Shields Health Solutions

Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
How Specialty Pharmacy Can Support Value-Based Care and Population Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Support Value-Based Care and Population Health
This white paper discusses how expanding integrated health system specialty pharmacy can be an impactful tool that health systems can leverage to improve their performance under value-based care contracts.
How Specialty Pharmacy Can Address and Impact Social Determinants of Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Address and Impact Social Determinants of Health
Social determinants of health can become barriers to patients receiving adequate health care and are drivers of most health outcomes.
Advancements in Rare Disease Treatment and Management 204 115 Shields Health Solutions

Advancements in Rare Disease Treatment and Management

This white paper discusses how health system-owned specialty pharmacies leveraging Shields’ integrated care model, data aggregation and acceleration solutions can overcome challenges and barriers to care for specialty patients with…

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers 204 115 Shields Health Solutions

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers

This white paper discusses how a specialty pharmacy acceleration company allows drug manufacturers to access the expertise of health systems and their specialty pharmacies through a single point of contact.…

  • 1
  • 2